We found that cell viability was not affected by treating chondrosarcoma cells or primary chondrocytes with 100 nm wild-type or mutant TIMP-3 for 2 days, in agreement with previous studies using wild-type N-TIMP-3 (6). The gene discussed is TIMP3; the disease is chondrosarcoma.